Halkeran

 0 people have bought this recently

Select the variant of Halkeran

Halkeran 2mg Tablet 30 टैबलेट 1 बोतल ₹ 1250
Halkeran 5mg Tablet 30 टैबलेट 1 बोतल ₹ 2900

Halkeran Information

Halkeran (Chlorambucil) is an alkylating agent used primarily in the treatment of certain cancers, including chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's lymphoma. Chlorambucil interferes with the DNA of cancer cells, inhibiting their ability to reproduce and proliferate. Chlorambucil is an alkylating agent that works by adding an alkyl group to the DNA molecule, which leads to the formation of DNA cross-links. This process prevents DNA from being able to replicate and causes cell death. By interfering with DNA replication and transcription, it inhibits the growth and division of cancer cells. Chlorambucil is considered a "mustard gas" derivative, a type of chemotherapy that acts at the cellular level.

Uses

Chronic Lymphocytic Leukemia (CLL):

  • Used for the treatment of CLL in both early and advanced stages, especially when the disease is not amenable to other therapies.

  • Chlorambucil can be used as a single agent or in combination with other medications.

Non-Hodgkin's Lymphoma (NHL):

  • Chlorambucil is used in the treatment of NHL, particularly in cases of indolent (slow-growing) lymphoma.

Hodgkin's Lymphoma:

  • Less commonly used but may be employed in specific cases, often in combination with other chemotherapy drugs.

Other Conditions:

  • Off-label use in various autoimmune disorders, such as systemic lupus erythematosus (SLE) and nephrotic syndrome, due to its immunosuppressive properties.

Halkeran (Chlorambucil) is an effective chemotherapy agent in the treatment of cancers like chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. However, due to its potential for serious side effects, including bone marrow suppression and liver toxicity, it requires careful monitoring and dose adjustment. Despite these risks, Chlorambucil remains an important option in the treatment of certain hematologic cancers.

Onset of Action- The onset of action for Chlorambucil can vary. For CLL, responses are often seen within a few weeks of treatment. However, significant clinical improvements may take several months to become fully apparent.

Duration of Action- Chlorambucil’s effects can persist for weeks to months, depending on the treatment regimen. Its impact on DNA synthesis can continue for a prolonged period after the drug has been cleared from the system.


Halkeran Benefits & Uses

Halkeran is used to treat the following -

Main Benefits

Other Benefits


Severe Interaction of Halkeran with Other Drugs

Halkeran should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Moderate


Halkeran Contraindications

If you are suffering from any of the following diseases, you should not take Halkeran unless your doctor advises you to do so -


Frequently asked Questions about Halkeran

  • Is this Halkeran habit forming or addictive?


    No, there is no any evidence that Halkeran is addictive.


This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience


BEST ALTERNATIVE
₹512 ₹995 48% OFF Save: ₹483
Multivitamin Capsules